Zepbound vs Mounjaro: One Molecule, Two Brand Labels

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

The PlexusDx Education Hub tracks the GLP-1 field, weight-management protocols, and the genetic variables underneath every metabolic decision. Browse all Peptides & GLP-1 education

This comparison is editorially independent. PlexusDx has no commercial relationship with Eli Lilly or Novo Nordisk.

Zepbound and Mounjaro generate a striking amount of confusion for one simple reason: they are the same molecule sold under two names. Both are Eli Lilly products built on tirzepatide, split apart by the indication each brand carries. This article, current as of April 2026, untangles why one active ingredient wears two labels — and the inherited biology that sits beneath both.

One molecule, two brand names

Zepbound and Mounjaro are both tirzepatide, marketed by Eli Lilly. Tirzepatide is a GIP and GLP-1 dual receptor agonist, engaging the GLP-1 receptor across the pancreas, hypothalamus, and gut while adding activity at the GIP receptor — the dual mechanism that distinguishes it from GLP-1-selective agonists such as semaglutide. Because the active ingredient is identical, the two brands differ not in pharmacology but in the label under which each is prescribed.

Why the FDA labels diverge

Mounjaro carries the type 2 diabetes indication (FDA-approved 2022). Zepbound carries chronic weight management (approved 2023 for adults with BMI ≥ 30, or ≥ 27 with a weight-related condition), with the indication expanded in 2024 to include moderate-to-severe obstructive sleep apnea in adults with obesity. Same tirzepatide, different approved use — and that labeling split is what determines how each is prescribed and whether insurance treats it as a covered benefit.

Reading the SURMOUNT and SURPASS record

Zepbound's weight-management evidence comes from the SURMOUNT program (with SURMOUNT-OSA covering sleep apnea), while Mounjaro's glycemic and weight data come from the SURPASS program in type 2 diabetes. Because the two brands are the same drug studied in different populations against different endpoints, the honest read is per-trial rather than a sweeping declaration that one brand outperforms the other.

A shared safety profile

Being one molecule, the two share a safety profile. Both carry the GLP-1 class boxed warning for thyroid C-cell tumor risk observed in rodent studies. The most common side effects are gastrointestinal — nausea, vomiting, diarrhea, and constipation — usually most pronounced during dose escalation. Serious events reported in the class include pancreatitis, gallbladder problems, and acute kidney injury in the setting of dehydration.

What the price tags reflect

Zepbound's U.S. list price sits at approximately $1,059 per month, and Mounjaro's at approximately $1,069 per month, per Eli Lilly published pricing as of April 2026. What you actually pay depends on insurance coverage, manufacturer savings cards, the FDA indication your prescription is written under, and whether a compounded alternative is available through a licensed compounding pathway.

The genetics upstream of tirzepatide

Whichever label a clinician prescribes, the inherited terrain is the same molecule's terrain. Variants in GIPR (the glucose-dependent insulinotropic polypeptide receptor, relevant to the GIP arm tirzepatide engages), GLP1R, FTO, and MC4R influence baseline appetite regulation, satiety signaling, and energy expenditure. They are pathway-level; they do not forecast response to tirzepatide, but they describe the biology it acts on.

PlexusDx offers tirzepatide through its Weight Management Protocols, including the Tirzepatide protocol. The upstream context is what sets the approach apart: before any GLP-1 pathway protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — including GIPR, GLP1R, FTO, and MC4R variants that shape your baseline GLP-1, appetite-regulation, and energy-balance biology. That is the test before you invest approach.

Related reading on PlexusDx: Mounjaro Price without Insurance, Mounjaro Weight Loss by Week, Mounjaro Compound, Mounjaro Discount.

Disclaimer: This article is educational. PlexusDx offers tirzepatide through its Weight Management Protocols and covers the mechanism, evidence, and genetic context that inform any decision to use it. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways; it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Explore the formats inside the PlexusDx Weight Management Protocols, or begin upstream with the Precision Peptide Genetic Test to understand your GLP-1 pathway before committing.

Frequently Asked Questions

Are Zepbound and Mounjaro the same drug?

Yes. Both are tirzepatide made by Eli Lilly, a GIP and GLP-1 dual receptor agonist. The difference is the FDA indication each brand carries — Mounjaro for type 2 diabetes, Zepbound for chronic weight management and obstructive sleep apnea — not the active ingredient or its mechanism.

Which brand is cheaper?

Their U.S. list prices are close — approximately $1,059 per month for Zepbound and $1,069 for Mounjaro per Eli Lilly published pricing as of April 2026. Actual out-of-pocket cost hinges on coverage, savings cards, and the indication on the prescription rather than the sticker gap between them.

Does insurance cover them differently?

Often, yes. Because coverage is tied to the FDA indication, a plan may cover Mounjaro for diabetes while excluding or restricting Zepbound for weight management, even though the molecule is identical. Coverage varies by plan, so confirm the specifics with your insurer and provider.

How does the Precision Peptide Genetic Test relate to tirzepatide?

It does not predict how tirzepatide will perform. The test analyzes pathway-level variants in GIPR, GLP1R, FTO, and MC4R that shape baseline GLP-1 and incretin biology — upstream context that applies whether the molecule is dispensed as Zepbound or Mounjaro. It is educational, not a response predictor.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.